• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于电子健康记录的门诊静脉抗生素治疗(OPAT)患者再入院风险模型的性能

Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).

作者信息

Drew Richard, Brenneman Ethan, Funaro Jason, Lee Hui-Jie, Yarrington Michael, Dicks Kristen, Gallagher David

机构信息

Duke University School of Medicine (Division of Infectious Diseases), Durham, North Carolina, United States of America.

Campbell University College of Pharmacy & Health Sciences, Buies Creek, North Carolina, United States of America.

出版信息

PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug.

DOI:10.1371/journal.pdig.0000323
PMID:37531342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10396003/
Abstract

BACKGROUND

Outpatient Parenteral Antibiotic Therapy (OPAT) provides coordinated services to deliver parenteral antibiotics outside of the acute care setting. However, the reduction in monitoring and supervision may impact the risks of readmission to the hospital. While identifying those at greatest risk of hospital readmission through use of computer decision support systems could aid in its prevention, validation of such tools in this patient population is lacking.

OBJECTIVE

The primary aim of this study is to determine the ability of the electronic health record-embedded EPIC Unplanned Readmission Model 1 to predict all-cause 30-day hospital unplanned readmissions in discharged patients receiving OPAT through the Duke University Heath System (DUHS) OPAT program. We then explored the impact of OPAT-specific variables on model performance.

METHODS

This retrospective cohort study included patients ≥ 18 years of age discharged to home or skilled nursing facility between July 1, 2019 -February 1, 2020 with OPAT care initiated inpatient and coordinated by the DUHS OPAT program and with at least one Epic readmission score during the index hospitalization. Those with a planned duration of OPAT < 7 days, receiving OPAT administered in a long-term acute care facility (LTAC), or ongoing renal replacement therapy were excluded. The relationship between the primary outcome (unplanned readmission during 30-day post-index discharge) and Epic readmission scores during the index admission (discharge and maximum) was examined using multivariable logistic regression models adjusted for additional predictors. The performance of the models was assessed with the scaled Brier score for overall model performance, the area under the receiver operating characteristics curve (C-index) for discrimination ability, calibration plot for calibration, and Hosmer-Lemeshow goodness-of-fit test for model fit.

RESULTS

The models incorporating maximum or discharge Epic readmission scores showed poor discrimination ability (C-index 0.51, 95% CI 0.45 to 0.58 for both models) in predicting 30-day unplanned readmission in the Duke OPAT cohort. Incorporating additional OPAT-specific variables did not improve the discrimination ability (C-index 0.55, 95% CI 0.49 to 0.62 for the max score; 0.56, 95% CI 0.49 to 0.62 for the discharge score). Although models for predicting 30-day unplanned OPAT-related readmission performed slightly better, discrimination ability was still poor (C-index 0.54, 95% CI 0.45 to 0.62 for both models).

CONCLUSION

EPIC Unplanned Readmission Model 1 scores were not useful in predicting either all-cause or OPAT-related 30-day unplanned readmission in the DUHS OPAT cohort. Further research is required to assess other predictors that can distinguish patients with higher risks of 30-day unplanned readmission in the DUHS OPAT patients.

摘要

背景

门诊肠外抗生素治疗(OPAT)提供协调服务,以便在急性护理环境之外给予肠外抗生素。然而,监测和监督的减少可能会影响再次入院的风险。虽然通过使用计算机决策支持系统识别那些再次入院风险最高的患者有助于预防再次入院,但缺乏对此类工具在该患者群体中的验证。

目的

本研究的主要目的是确定嵌入电子健康记录的EPIC非计划再入院模型1预测通过杜克大学健康系统(DUHS)OPAT计划接受OPAT治疗的出院患者30天内全因非计划再入院的能力。然后,我们探讨了OPAT特定变量对模型性能的影响。

方法

这项回顾性队列研究纳入了2019年7月1日至2020年2月1日期间出院回家或入住熟练护理机构、在住院期间开始接受OPAT护理并由DUHS OPAT计划协调、且在索引住院期间至少有一个Epic再入院评分的18岁及以上患者。计划OPAT持续时间<7天、在长期急性护理机构(LTAC)接受OPAT治疗或正在进行肾脏替代治疗的患者被排除。使用针对其他预测因素进行调整的多变量逻辑回归模型,研究主要结局(索引出院后30天内的非计划再入院)与索引入院期间(出院时和最高值)的Epic再入院评分之间的关系。使用缩放Brier评分评估模型的整体性能、使用受试者操作特征曲线下面积(C指数)评估判别能力、使用校准图评估校准情况、使用Hosmer-Lemeshow拟合优度检验评估模型拟合情况。

结果

纳入最高值或出院时Epic再入院评分的模型在预测杜克OPAT队列中30天非计划再入院方面显示出较差的判别能力(两个模型的C指数均为0.51,95%CI为0.45至0.58)。纳入额外的OPAT特定变量并未提高判别能力(最高值评分模型的C指数为0.55,95%CI为0.49至0.62;出院评分模型的C指数为0.56,95%CI为0.49至0.62)。尽管预测30天非计划OPAT相关再入院的模型表现稍好,但判别能力仍然较差(两个模型的C指数均为0.54,95%CI为0.45至0.62)。

结论

EPIC非计划再入院模型1评分在预测DUHS OPAT队列中全因或OPAT相关再入院方面无用。需要进一步研究以评估其他可区分DUHS OPAT患者中30天非计划再入院高风险患者的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/eed34e832b6d/pdig.0000323.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/771355f6fdcd/pdig.0000323.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/8e0c1da2295d/pdig.0000323.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/eed34e832b6d/pdig.0000323.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/771355f6fdcd/pdig.0000323.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/8e0c1da2295d/pdig.0000323.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/833f/10396003/eed34e832b6d/pdig.0000323.g003.jpg

相似文献

1
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).基于电子健康记录的门诊静脉抗生素治疗(OPAT)患者再入院风险模型的性能
PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug.
2
Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.风险评估模型在预测接受门诊胃肠外抗菌治疗的成年患者30天非计划再次住院中的效用。
JAC Antimicrob Resist. 2023 Feb 21;5(1):dlad019. doi: 10.1093/jacamr/dlad019. eCollection 2023 Feb.
3
External validation of EPIC's Risk of Unplanned Readmission model, the LACE+ index and SQLape as predictors of unplanned hospital readmissions: A monocentric, retrospective, diagnostic cohort study in Switzerland.EPIC 的再入院风险模型、LACE+ 指数和 SQLape 作为非计划性住院再入院预测因子的外部验证:瑞士单中心回顾性诊断队列研究。
PLoS One. 2021 Nov 12;16(11):e0258338. doi: 10.1371/journal.pone.0258338. eCollection 2021.
4
Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.开发门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型。
Clin Microbiol Infect. 2019 Jul;25(7):905.e1-905.e7. doi: 10.1016/j.cmi.2018.11.009. Epub 2018 Nov 28.
5
An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.接受门诊胃肠外抗菌治疗患者再入院风险因素的评估。
Ther Adv Infect Dis. 2023 Sep 1;10:20499361231195966. doi: 10.1177/20499361231195966. eCollection 2023 Jan-Dec.
6
Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.安全网医院出院的未参保患者自我管理门诊抗菌药物输注:一项倾向评分平衡的回顾性队列研究。
PLoS Med. 2015 Dec 15;12(12):e1001922. doi: 10.1371/journal.pmed.1001922. eCollection 2015 Dec.
7
Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.接受门诊胃肠外抗生素治疗出院患者30天内再入院的预测模型
Clin Infect Dis. 2014 Mar;58(6):812-9. doi: 10.1093/cid/cit920. Epub 2013 Dec 19.
8
Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network.大型综合医疗网络中接受门诊胃肠外抗菌治疗患者非计划住院的预测因素
Open Forum Infect Dis. 2017 Jun 16;4(2):ofx086. doi: 10.1093/ofid/ofx086. eCollection 2017 Spring.
9
External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.接受门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型的外部有效性和临床实用性。
J Antimicrob Chemother. 2021 Jul 15;76(8):2204-2212. doi: 10.1093/jac/dkab127.
10
Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions.布朗克斯区的综合措施:门诊肠外抗生素治疗综合措施对全因30天再入院率的影响。
Open Forum Infect Dis. 2017 Jun 29;4(2):ofx097. doi: 10.1093/ofid/ofx097. eCollection 2017 Spring.

引用本文的文献

1
A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023.2023年“十大”门诊肠外抗菌治疗出版物汇总
Open Forum Infect Dis. 2024 Oct 29;11(11):ofae635. doi: 10.1093/ofid/ofae635. eCollection 2024 Nov.
2
Creation and Validation of an Automated Registry for Outpatient Parenteral Antibiotics.门诊胃肠外抗生素自动登记系统的创建与验证
Open Forum Infect Dis. 2024 Jan 12;11(2):ofae004. doi: 10.1093/ofid/ofae004. eCollection 2024 Feb.

本文引用的文献

1
Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.风险评估模型在预测接受门诊胃肠外抗菌治疗的成年患者30天非计划再次住院中的效用。
JAC Antimicrob Resist. 2023 Feb 21;5(1):dlad019. doi: 10.1093/jacamr/dlad019. eCollection 2023 Feb.
2
Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study.门诊胃肠外抗菌治疗(OPAT)并发症相关危险因素评估:一项回顾性队列研究。
Antimicrob Steward Healthc Epidemiol. 2022 Nov 11;2(1):e183. doi: 10.1017/ash.2022.313. eCollection 2022.
3
A Readmission Risk Model for Hospitalized Patients Receiving Dialysis: Evaluation of Predictive Performance.
接受透析治疗的住院患者再入院风险模型:预测性能评估。
Kidney Med. 2022 Jun 24;4(8):100507. doi: 10.1016/j.xkme.2022.100507. eCollection 2022 Aug.
4
Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.住院药师使用再入院风险模型支持出院药物重整以减少非计划性医院再入院:一项质量改进干预措施。
BMJ Open Qual. 2022 Mar;11(1). doi: 10.1136/bmjoq-2021-001560.
5
External validation of EPIC's Risk of Unplanned Readmission model, the LACE+ index and SQLape as predictors of unplanned hospital readmissions: A monocentric, retrospective, diagnostic cohort study in Switzerland.EPIC 的再入院风险模型、LACE+ 指数和 SQLape 作为非计划性住院再入院预测因子的外部验证:瑞士单中心回顾性诊断队列研究。
PLoS One. 2021 Nov 12;16(11):e0258338. doi: 10.1371/journal.pone.0258338. eCollection 2021.
6
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.英国成人及儿童门诊胃肠外抗菌治疗(OPAT)的最新良好实践建议。
JAC Antimicrob Resist. 2019 Aug 26;1(2):dlz026. doi: 10.1093/jacamr/dlz026. eCollection 2019 Sep.
7
External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.接受门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型的外部有效性和临床实用性。
J Antimicrob Chemother. 2021 Jul 15;76(8):2204-2212. doi: 10.1093/jac/dkab127.
8
External validation of a clinical risk score to predict hospital admission and in-hospital mortality in COVID-19 patients.对一种临床风险评分模型进行外部验证,以预测 COVID-19 患者的住院和院内死亡率。
Ann Med. 2021 Dec;53(1):78-86. doi: 10.1080/07853890.2020.1828616. Epub 2020 Oct 9.
9
Implementation and Continuous Monitoring of an Electronic Health Record Embedded Readmissions Clinical Decision Support Tool.电子健康记录嵌入式再入院临床决策支持工具的实施与持续监测
J Pers Med. 2020 Aug 26;10(3):103. doi: 10.3390/jpm10030103.
10
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.